What helps / Medication

Pregabalin and gabapentin

Medicines first made for epilepsy and nerve pain. A few placebo-controlled trials show they reduce social anxiety, often only at high doses. Misuse and withdrawal are real concerns.

Some evidence

A few placebo-controlled trials show a benefit, but lower doses of pregabalin did not beat placebo, and there are no head-to-head trials against SSRIs. Concerns about misuse and dependence also weigh against them. How we rate evidence

At a glance

Compared with waiting
In a combined analysis of 101 trials, this group of medicines showed a large difference compared with waiting.
Compared with other treatments
Better than placebo in a few trials. In a trial of 329 people, only the highest pregabalin dose tested beat placebo.
Does it last
In a trial of 153 people who had improved on pregabalin, those who stayed on it relapsed later than those switched to placebo.
What it takes
Daily tablets, prescribed and reviewed by a doctor.

What they are

Pregabalin and gabapentin are related medicines. They were first used for epilepsy and nerve pain. Doctors sometimes prescribe them for anxiety. They are sometimes called gabapentinoids. A doctor decides whether one suits you and at what dose.

What people report

On Reddit, a minority of people say pregabalin or gabapentin helped them more than anything else. Others warn about feeling dependent on them and about withdrawal when stopping. These are reports from people, not trial results.

What the trials show

What the trials have not answered

Side effects and risks

Stopping

Do not stop suddenly or change the dose without your doctor. Stopping pregabalin suddenly can cause withdrawal symptoms, including trouble sleeping, nausea, diarrhoea, headaches or seizures. Your doctor can plan a slow reduction.

Medication or therapy?

There is no single ranking. Compared with their own starting point, medicines can look stronger than therapy. Compared with a placebo or waiting, individual CBT made for social anxiety had the largest effect. SSRIs and SNRIs explains why the answer depends on the comparison.

For most people, SSRIs and SNRIs and cognitive therapy for social anxiety are better-tested first steps.

Myths and facts

Myth:Gabapentin is a safe, non-addictive alternative to benzos.

Fact:Misuse and withdrawal are documented. In the UK, both pregabalin and gabapentin became controlled drugs in 2019 because of rising deaths linked to them.

Sources

  1. Mayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, Ades AE, Pilling S (2014). Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis.Lancet Psychiatry.
  2. Williams T, Hattingh CJ, Kariuki CM, Tromp SA, van Balkom AJ, Ipser JC, Stein DJ (2017). Pharmacotherapy for social anxiety disorder (SAnD).Cochrane Database of Systematic Reviews.
  3. Feltner DE, Liu-Dumaw M, Schweizer E, Bielski R (2011). Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.International Clinical Psychopharmacology.
  4. Greist JH, Liu-Dumaw M, Schweizer E, Feltner D (2011). Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.International Clinical Psychopharmacology.
  5. Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, Greist JH, Sutherland SM (1999). Treatment of social phobia with gabapentin: a placebo-controlled study.Journal of Clinical Psychopharmacology.
  6. Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, et al. (2014). Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.BMC Psychiatry.
  7. UK Government: Pregabalin and gabapentin to be controlled as Class C drugs (2018)
  8. MedlinePlus: Pregabalin (US National Library of Medicine)
  9. MedlinePlus: Gabapentin (US National Library of Medicine)
  10. NICE CG159: Social anxiety disorder (UK guideline)